Development of the NeuroFlow Severity Score and Comparison With Validated Measures for Depression and Anxiety
William Lynch, Michael L. Platt, View ORCID ProfileAdam Pardes
doi: https://doi.org/10.1101/2021.02.04.21251158
William Lynch
1NeuroFlow, Inc., Philadelphia, PA
Roles: Data Science Manager
Michael L. Platt
2James S. Riepe University Professor, Departments of Neuroscience, Psychology, and Marketing, University of Pennsylvania, Philadelphia, PA
PhDAdam Pardes
3NeuroFlow, Inc., 111 S Independence Mall E, Suite 701, Philadelphia, PA, 19106
MSERoles: Chief Operating Officer
Data Availability
Deidentified data are available from the corresponding author for researchers who meet the criteria for access and collaboration.
Posted February 08, 2021.
Development of the NeuroFlow Severity Score and Comparison With Validated Measures for Depression and Anxiety
William Lynch, Michael L. Platt, Adam Pardes
medRxiv 2021.02.04.21251158; doi: https://doi.org/10.1101/2021.02.04.21251158
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (629)
- Anesthesia (166)
- Cardiovascular Medicine (2388)
- Dermatology (207)
- Emergency Medicine (380)
- Epidemiology (11783)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3758)
- Geriatric Medicine (350)
- Health Economics (636)
- Health Informatics (2402)
- Health Policy (935)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (366)
- Medical Ethics (105)
- Nephrology (400)
- Neurology (3515)
- Nursing (199)
- Nutrition (528)
- Oncology (1827)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (66)
- Pathology (447)
- Pediatrics (1035)
- Primary Care Research (423)
- Public and Global Health (6156)
- Radiology and Imaging (1283)
- Respiratory Medicine (830)
- Rheumatology (379)
- Sports Medicine (324)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)